The Promise of MCDA to Improve Equity in Value Assessment
In a commentary in AJMC, IVI examines how multi-criteria decision analysis has the potential to better understand and assess value for innovative cell and gene therapies which are transforming the lives of patients living with serious diseases. Read the full article here.
Can Depression Help Employers Improve Their Value Assessment Methods?
IVI’s Jennifer Bright and Mike Thompson of the National Alliance for Healthcare Purchasers share how employers can use depression as a “test case” for thinking about how to improve the value assessment process, so that we can apply a “purchaser-patient” lens up front. Read the full article on Employers Benefit News here.
How IVI Puts Patients at the Center of Value Assessment
Central to IVI’s work is ensuring patient perspectives are included at the front of all value assessments. This short video explains why and how IVI incorporates lived experience in its modeling.
Value Assessment During the COVID-19 Pandemic
The COVID-19 pandemic is raising new questions about how we approach value assessment. As always, IVI urges experts to use transparency, real world data, and seek consensus. Sam Nussbaum, President of the IVI Board of Directors, shares his thoughts in a commentary in STAT. Read the full commentary here.
Why Accounting for Our Differences Matter in Assessing Drug Value
IVI’s Jennifer Bright and Amy Miller, former CEO of the Society for Women’s Health Research, explain why patient heterogeneity is crucial to consider in any value assessment method. Read the full article here.
Experts Address Gaps in Value Assessment
Previewing their panel discussion at ISPOR 2020, Lou Garrison and Leah Howard discuss what’s needed to address gaps on value assessment. View the short video clip here.
IVI Shares Executive Summary of Annual Methods Summit
The national dialogue on value in health care is bringing to the forefront the limitations of current value assessment methods and gaps in real world data to inform decision-making. IVI seeks to engage a wider group of stakeholders to inform priorities in methods research and to invest resources and expertise in improving value assessment. Toward […]
New Career Opportunities at IVI
IVI has announced two new job opportunities at IVI: Research Manager Operations Manager Please visit our Careers page for job details and application instructions. If you have any questions, please feel free to contact us at info@thevalueinitiative.org.
Special Issue of AJMC on HCV: Access, Value, and Cost of Innovative Therapies
In a special issue of The American Journal of Managed Care (AJMC) on the Hepatitis C virus, released May 2016, IVI authors take up multiple key issues at the intersection of access, cost, and value from recent innovations in HCV treatment in four separate articles: “Does Patient Cost Sharing for HCV Drug Make Sense?” authored by Darius Lakdawalla, […]
Panel of Health Advisors to Determine IVI Research Agenda at Inaugural Meeting in 2016’Q4
When the IVI Panel of Health Advisors convenes its inaugural meeting in the fourth quarter of 2016, it will establish the IVI research agenda for late 2016 and early 2017. Initial research priorities may focus on specific issues in value measurement and policy reforms, with focus on a few particularly salient therapeutic areas. Research priorities […]